Lawmakers were expected to approve a bill that would allow doctors to help terminally ill patients to die. If the law passes, ...
Pete Hegseth said the Pentagon will begin requiring testosterone deficiency screenings for active-duty service members over ...
Health system and hospital pharmacy departments are heading into next year with a familiar set of pressures: a shrinking graduate pipeline, unpredictable drug shortages, evolving 340B and ...
Compass Therapeutics is rated Buy, with risk/reward favoring upside after a sharp post-data selloff. Click here to read more ...
Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to its full-year guidance. We're not rattled by the market reaction and believe the reasons ...
Sudden vision loss or blurring while taking GLP-1s should be treated as a medical emergency, an expert told Newsweek.
Doctors say the risk of Cyclospora from lettuce remains extremely low, but recommend washing all leafy greens thoroughly amid ...
Over 7,000 cases tied to the multistate outbreak of cyclospora are confirmed, though experts warn of more parasites.
Built from graphene and tested on tears, the non-invasive device is already eyeing a startup spin-off to bring low-cost ...
Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Barbie Cervoni, MS, RD, CD/N, CDE, is a registered dietitian (RD ...
I n 1876 Eli Lilly, a veteran of the civil war, founded a company in Indianapolis to bring scientific rigour to a medicines ...
Celcuity wins FDA approval for REVTORPYK in HR+/HER2- breast cancer; outlook tempered by phase 3 data, competition & launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results